Sumitomo Pharma Co., Ltd.
4506.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥23,635 | -¥314,929 | -¥96,714 | ¥40,600 |
| Dep. & Amort. | ¥25,562 | ¥37,765 | ¥41,263 | ¥38,348 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥18,770 | -¥95,847 | ¥34,878 | -¥33,733 |
| Other Non-Cash | -¥13,927 | ¥131,118 | ¥32,510 | -¥13,976 |
| Operating Cash Flow | ¥16,500 | -¥241,893 | ¥11,937 | ¥31,239 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥8,498 | -¥15,730 | -¥12,742 | -¥13,494 |
| Net Acquisitions | ¥1,458 | ¥8,605 | ¥30,172 | -¥3,701 |
| Inv. Purchases | -¥1,645 | -¥4,772 | -¥6,247 | -¥25,905 |
| Inv. Sales/Matur. | ¥108,491 | ¥34,499 | ¥10,068 | ¥19,472 |
| Other Inv. Act. | -¥52 | ¥10,434 | ¥31,168 | ¥5,350 |
| Investing Cash Flow | ¥99,754 | ¥33,036 | ¥52,419 | -¥18,278 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥112,485 | ¥84,000 | ¥65,499 | -¥4,931 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥3 | -¥2,792 | -¥11,125 | -¥11,126 |
| Other Fin. Act. | ¥3,652 | -¥3,357 | -¥201,191 | -¥5,369 |
| Financing Cash Flow | -¥108,836 | ¥77,851 | -¥146,817 | -¥21,426 |
| Forex Effect | -¥177 | ¥15,440 | ¥24,090 | ¥17,751 |
| Net Chg. in Cash | -¥5,931 | -¥114,431 | -¥59,506 | ¥9,286 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥29,047 | ¥143,478 | ¥202,984 | ¥193,698 |
| End Cash | ¥23,116 | ¥29,047 | ¥143,478 | ¥202,984 |
| Free Cash Flow | ¥3,470 | -¥257,623 | -¥805 | ¥17,745 |